CAO Xuetao, Vice-Chairman of Committee on Education, Science, Health and Sports of National Committee of the Chinese People's Political Consultative Conference (CPPCC) ,
Academician of Chinese Academy of Engineering, Chief Engineer of National Science and Technology Major Project for Innovative Drug R&D
09:20 - 09:50
主旨报告2
Keynote Speech 2
病原体与大健康
Pathogen and Public Health
饶子和, 中国科学院院士、清华大学基础医学院教授
RAO Zihe, Member of the Chinese Academy of Sciences (MCAS), Professor of Tsinghua University
09:50 - 10:10
主旨报告3
Keynote Speech 3
全球变局下中国医药创新产业格局重塑中的新机遇
New Opportunities in Reshaping the Structure of China's Pharmaceutical Innovation Industry under Global Changes
宋瑞霖, 中国医药创新促进会资深会长、首席专家
SONG Ruilin, Eminent President & Chief Expert of PhIRDA
10:10 - 12:00
第三阶段：专题讨论
Session III: Panel Discussion
10:10 - 11:05
专题讨论1
Panel 1
创十年，砥砺铸新章——从跟随式创新走向源头创新，从本土布局到全球突围
A Decade of Innovation, Forging New Chapters
--From Follower to Forerunner in Innovation, From Domestic Footprint to Global Breakthrough
主持人 Moderator
吴晓滨, 中国医药创新促进会资深会长/百济神州全球总裁兼首席运营官
WU Xiaobin, Eminent President of PhIRDA / President & Chief Operating Officer of BeOne Medicines
讨论嘉宾： Panelist:
黄晓军, 北京大学血液病研究所所长，国家血液系统疾病临床医学研究中心主任
HUANG Xiaojun, Chairman of Peking University Institute of Hematology, PUPH,
Director of National Clinical Research Center for Hematologic Diseases
李佳, 中国医药创新促进会副会长/中国科学院上海药物研究所所长
LI Jia, Vice President of PhIRDA / Director of Shanghai Institute of Materia Medica, Chinese Academy of Sciences
刘殿波, 中国医药创新促进会副会长/绿叶生命科学集团董事局主席
LIU Dianbo, Vice President of PhIRDA / Chairman of the Board, Luye Life Sciences Group
张连山, 江苏恒瑞医药股份有限公司董事、执行副总裁
ZHANG Lianshan , Board Director, Executive Vice President of Jiangsu Hengrui Pharmaceuticals
朱义, 百利天恒药业股份有限公司创始人、董事长、首席科学官
ZHU Yi, Founder, Chairman, Chief Science Officer of Biokin Pharmaceutical
李蕾, 思拓凡中国总裁
Allen LI, President of Cytiva China
11:05 - 12:00
专题讨论2
Panel 2
投未来，翱翔拓新程——资本周期与产业变革交汇，大国博弈辨识产业先机
Invest in the Future, Soaring to New Journeys
-- Capital Return meets Industrial Revolution, Seek Opportunities among Great Power Rivalry
主持人 Moderator
陈启宇, 中国医药创新促进会资深会长/复星国际执行董事兼联席首席执行官
CHEN Qiyu, Eminent President of PhIRDA / Executive Director & Co-CEO of Fosun International
讨论嘉宾： Panelist:
丁列明, 中国医药创新促进会副会长/贝达药业股份有限公司董事长兼首席执行官
DING Lieming, Vice President of PhIRDA / Chairman of the Board & CEO of Betta Pharmaceuticals
杨大俊, 亚盛医药董事长兼首席执行官
YANG Dajun , Chairman of the Board & CEO of Ascentage Pharmaceutical
朱忠远, 映恩生物创始人兼首席执行官
John ZHU, Founder, CEO and Chairman of Duality Biotherapeutics
方敏, 华平投资董事总经理，中国私募股权投资联席总裁
FANG Min, Managing Director, Co-Head of China Private Equity of Warburg Pincus
李振福, 德福资本创始合伙人兼首席执行官
Jeffrey LI, Founding Partner & CEO of GL Capital Group
许小林, 华盖资本创始合伙人、董事长
XU Xiaolin, Founding Partner and Chairman of Huagai Capital
张书明, 香港交易所高级副总裁兼亚洲区上市发行服务部主管
Kelvin Teo, Senior Vice President, Head of Asia of Global Issuer Services of HKEX
会议咨询